recombinant DNA technology
英
美 [rɪˈkɑmbɪnənt ˌdiː en ˈeɪ tekˈnɑːlədʒi]
网络 DNA重组技术; 技术; 重组DNA技术; 重组; 重组 DNA技术
双语例句
- Construction of an Amylolytic and Ethanol-producing Yeast Strain by Recombinant DNA Technology
用基因重组技术构建可降解淀粉和产生酒精的酵母工程菌 - As recombinant DNA technology is consummating increasingly, genetic engineering drug is frequently researched and utilized.
随着重组DNA技术的不断完善，基因工程药物的研制和利用日益增多。 - With the development of recombinant DNA technology and expression system, quantity of known protein increases.
随着重组DNA技术的发展和表达体系的完善，已知的蛋白质数目有了很大增长。 - Recombinant chymosin represents one of the first successful applications of recombinant DNA technology in the food industry.
重组凝乳酶是重组DNA技术在食品工业中的首次成功应用。 - Application of recombinant DNA technology in entomology
重组DNA技术在昆虫学中的应用 - Recombinant DNA technology, transgenic technology is also a matter of fact in the molecular level to create the mosaic.
重组DNA技术、转基因技术事实上也都是在制造分子层次上的嵌合体。 - Although the traditional amino acid producing methods such as chemical synthesis and isolation from natural sources are still utilized, the most significant trend in amino acid production technique is the swift and violent development of multiple method and biological synthesis, especially the application of recombinant DNA technology.
生物资源提取、化学合成、生物合成和综合法是生产氨基酸的4种技术，目前的发展趋势为生物合成和综合法，特别是将现代生物工程技术应用于氨基酸生产。 - Methods: An artificial egf gene was constructed with recombinant DNA technology and inserted into pQE-40 to get a expression plasmid pQE-EGF, in which egf was fused with 6 × His tag. Plasmid pQE-EGF was transformed into E.
方法：用DNA重组技术构建EGF基因并插入表达载体pQE-40，与载体上的6×His标签融合，获得的表达质粒pQE-EGF转化E。 - The advent of recombinant DNA technology has provided efficient and cost-effective alternate sources for many therapeutic proteins.
重组DNA技术为许多治疗性蛋白的生产提供了一种有效的替代方法。 - Prophylactic vaccines based on the use of virus-like particles ( VLPs) obtained from auto-assembly of L1 or L1 and L2 proteins produced by recombinant DNA technology are under phase I/ II clinical trials for HPV6/ 11 associated with condylomas.
通过DNA重组技术，基于HPV6/11型L1或L1和L2蛋白自我组装成病毒样颗粒的研究已经进入了I/II期临床实验。